Sysmex (TSE:6869) Change In Receivables : 円-8,967 Mil (TTM As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Sysmex Change In Receivables?

Sysmex's change in receivables for the quarter that ended in Dec. 2023 was 円-5,649 Mil. It means Sysmex's Accounts Receivable increased by 円5,649 Mil from Sep. 2023 to Dec. 2023 .

Sysmex's change in receivables for the fiscal year that ended in Mar. 2023 was 円-2,980 Mil. It means Sysmex's Accounts Receivable increased by 円2,980 Mil from Mar. 2022 to Mar. 2023 .

Sysmex's Accounts Receivable for the quarter that ended in Dec. 2023 was 円132,749 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sysmex's Days Sales Outstanding for the three months ended in Dec. 2023 was 106.42.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sysmex's liquidation value for the three months ended in Dec. 2023 was 円40,845 Mil.

Sysmex Change In Receivables Historical Data

The historical data trend for Sysmex's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Change In Receivables Chart

Sysmex Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Receivables

Get a 7-Day Free Trial

-11,988.00

-4,423.00

-9,066.00

-10,297.00

-2,980.00

Sysmex Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-7,637.00	-6,430.00	12,462.00	-9,350.00	-5,649.00

Sysmex Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-8,967 Mil.

Sysmex (TSE:6869) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sysmex's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	132749	/	113826	*	91
=	106.42

2. In Ben Graham's calculation of liquidation value, Sysmex's accounts receivable are only considered to be worth 75% of book value:

Sysmex's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	60694	-	160273	+	0.75 * 132749	+	0.5 * 81724
=	40,845

Sysmex Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sysmex's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sysmex (TSE:6869) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (TSE:6869) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

SSMXY:USA SSMXF:USA 0YX:Germany

Address

1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073

Website

http://www.sysmex.co.jp

Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (TSE:6869) Headlines

No Headlines